Luminor 14m: Dilatation of stenosis in femoral, popliteal and infra-popliteal arteries.
Luminor 18: Dilatation of stenosis in iliac, femoral, iliofemoral, popliteal, infra-popliteal and renal arteries, as well as for the treatment of obstructive lesions of arteriovenous fistulas.
Luminor 35: Dilation of stenosis located in the iliac, femoral, ilio-femoral, popliteal, infra-popliteal and renal arteries, as well as for the treatment of obstructive lesions of arteriovenous fistulas.
Luminor paclitaxel-eluting balloon is a double lumen catheter from the connector to the tip (also called over-the-wire, OTW) designed for percutaneous transluminal angioplasties of large peripheral arteries.
The guidewire runs into the circular-largest lumen while the elliptic-smallest lumen is intended for contrast medium flow.
The maximum diameter of the guidewire must not exceed 0.89 mm = 0.035 inches.
On the catheter’s distal part, just before the tip, there is the balloon (inflatable segment) that will dilate the artery upon inflating through the infusion of contrast fluid inside of it. The connector is Y-shaped and it has two entry ports:
• The straight portis intended for guidewire passage.
• The side port allows contrast medium flow to dilate the balloon
Luminor is coated with a homogeneous mixture of paclitaxel, a derivative of Taxol, and a physiologically innocuous matrix, the excipient. Drug’s dose is 3 µg/mm2 of balloon surface and it is intended to avoid cellular proliferation, consequently decreasing re-intervention rate.
The drug is released from the balloon by means of rapid inflation so that a high dose is released in a very short period of time. To assure a sufficient dosage of paclitaxel into the arterial wall, the inflation process must last from 30 seconds to 1 minute. Dilation of the lesion can be optimised by using longer inflation times at the operator’s discretion.
The balloon is designed to reach different diameters at different pressures, as predicted by the compliance curve included in the primary packaging.
Two radiopaque markers of Pt/Ir alloy are located at each end of the balloon to mark its length and help the user to see the catheter while navigating inside the patient.
At the distal end, there is the tip, made from a very soft polymer and rounded forming a non-traumatic shape to avoid damaging the arterial wall while navigating.
The shaft of the catheter is coated with a proprietary hydrophilic formula to minimise friction.
Barcelona, September 21th, 2017
iVascular S.L.U. has announced that Luminor 14m, the Drug Coated Balloon (DCB) indicated for below the knee BTK arteries, has received the Canadian Medical Device License (MDL).
Luminor 14m is a Paclitaxel Coated Balloon specifically designed for BTK indications, thanks to its extra low crossing profile combined with TransferTechTM, iVascular proprietary technology for drug release.
Lluis Duocastella, CEO of iVascular S.L.U., asserted: “The Luminor 14m MDL represents a key milestone for iVascular on the Canadian market. It opens a new horizon for our Endovascular product portfolio and will provide Canadian patients and physicians with the latest technology available to treat Critical Limb Ischemia.”
The Platform-14 Team
We are an independent, imaginative, and dynamic organisation, pioneering a new way for medical distribution in the UK and across Europe. Our team is knowledgeable yet inquisitive, driven but flexible, great at communicating but equally, good listeners.
We believe that our people shape our future and drive our success.
We continuously work to develop our team to help them provide a first-class service for our customers and supplier partners.
Let's Work Together
It’s simple – here at Platform 14 we will work with you, as your partner to drive your sales, market penetration and profitability within your chosen market. In addition, you will benefit from our years of experience launching and cultivating products within the UK and European markets.
At Platform 14, we nurture and take great pride in understanding and expanding our partnership network. We exist for our partners success and welcome new partners into our expanding healthcare product distribution network.
If you are interested in working with Platform-14, please fill out the form below. We look forward to hearing from you.